Is CJC-1295 or Ipamorelin better for someone over 40?

It depends on the goal, but most practitioners recommend the two together for men over 40. CJC-1295 raises the baseline and favors lean mass and collagen, while Ipamorelin drives a sharp clean pulse and is associated with fat loss, recovery, and sleep. Aging reduces both the size and frequency of natural pulses, and the combination addresses both at once.

How long before I notice results?

The commonly reported timeline is sleep and recovery improvements in the first one to two weeks, more energy through weeks two to four, and visible body composition change between weeks six and twelve. Full benefits usually require completing a three to six month cycle. Individual response varies, and none of it works without training, protein, and sleep in place.

Does Ipamorelin raise cortisol or make you hungry?

Ipamorelin is considered the cleanest peptide in its class largely because it does not meaningfully raise cortisol or prolactin, which were problems with older growth hormone releasing peptides. It can have a mild effect through the ghrelin pathway, but it is far more selective than earlier compounds, which is why it is favored for body composition goals.

What is the difference between CJC-1295 with DAC and without DAC?

The DAC, or drug affinity complex, dramatically extends the half-life. CJC-1295 with DAC lasts for days and requires fewer injections, giving a long sustained IGF-1 elevation that suits anti-aging and collagen goals. Without DAC, sometimes labeled Modified GRF 1-29, it clears faster and offers tighter control over pulse timing, at the cost of more frequent dosing.

Are these peptides safe and legal?

They are not FDA approved for anti-aging or performance and occupy a regulatory gray area, so they should only be used under medical supervision with regular lab monitoring. Human studies are limited in size and mostly measure hormone levels. Reported side effects are generally mild, such as injection site irritation, occasional headache, or water retention, but individual risk varies.

Somatopause is the gradual age related decline in growth hormone output that begins around age 30 and continues for life, falling roughly 14 percent per decade. It shows up as less lean mass, more visceral fat, thinner skin, lighter sleep, and slower recovery, and it is the process these peptides aim to push back against.

Do I have to inject CJC-1295 and Ipamorelin?

In research and clinical settings both are given by subcutaneous injection. CJC-1295 with DAC requires the fewest injections because of its multi day half-life, while Ipamorelin's short two hour half-life means more frequent dosing. Injection frequency is one of the practical trade-offs practitioners weigh when designing a protocol.

Do the benefits last after stopping?

These secretagogues amplify your own pulsatile growth hormone release while you use them, so the hormonal effect fades once you stop and IGF-1 returns toward your baseline for your age. Gains in muscle and body composition can be maintained with continued training, protein, and sleep, but the underlying somatopause decline resumes without the peptides.

Is CJC-1295 or Ipamorelin better for someone over 40?

It depends on the goal, but most practitioners recommend the two together for men over 40. CJC-1295 raises the baseline and favors lean mass and collagen, while Ipamorelin drives a sharp clean pulse and is associated with fat loss, recovery, and sleep. Aging reduces both the size and frequency of natural pulses, and the combination addresses both at once.

How long before I notice results?

The commonly reported timeline is sleep and recovery improvements in the first one to two weeks, more energy through weeks two to four, and visible body composition change between weeks six and twelve. Full benefits usually require completing a three to six month cycle. Individual response varies, and none of it works without training, protein, and sleep in place.

Does Ipamorelin raise cortisol or make you hungry?

Ipamorelin is considered the cleanest peptide in its class largely because it does not meaningfully raise cortisol or prolactin, which were problems with older growth hormone releasing peptides. It can have a mild effect through the ghrelin pathway, but it is far more selective than earlier compounds, which is why it is favored for body composition goals.

What is the difference between CJC-1295 with DAC and without DAC?

The DAC, or drug affinity complex, dramatically extends the half-life. CJC-1295 with DAC lasts for days and requires fewer injections, giving a long sustained IGF-1 elevation that suits anti-aging and collagen goals. Without DAC, sometimes labeled Modified GRF 1-29, it clears faster and offers tighter control over pulse timing, at the cost of more frequent dosing.

Are these peptides safe and legal?

They are not FDA approved for anti-aging or performance and occupy a regulatory gray area, so they should only be used under medical supervision with regular lab monitoring. Human studies are limited in size and mostly measure hormone levels. Reported side effects are generally mild, such as injection site irritation, occasional headache, or water retention, but individual risk varies.

Somatopause is the gradual age related decline in growth hormone output that begins around age 30 and continues for life, falling roughly 14 percent per decade. It shows up as less lean mass, more visceral fat, thinner skin, lighter sleep, and slower recovery, and it is the process these peptides aim to push back against.

Do I have to inject CJC-1295 and Ipamorelin?

In research and clinical settings both are given by subcutaneous injection. CJC-1295 with DAC requires the fewest injections because of its multi day half-life, while Ipamorelin's short two hour half-life means more frequent dosing. Injection frequency is one of the practical trade-offs practitioners weigh when designing a protocol.

Do the benefits last after stopping?

These secretagogues amplify your own pulsatile growth hormone release while you use them, so the hormonal effect fades once you stop and IGF-1 returns toward your baseline for your age. Gains in muscle and body composition can be maintained with continued training, protein, and sleep, but the underlying somatopause decline resumes without the peptides.

GH STACK

CJC-1295 vs Ipamorelin

Peptide Therapy

CJC-1295 vs Ipamorelin: Which GH Peptide Stack Delivers After 40

July 6, 20269 min readBy Epithalon Editorial

Somewhere in your late thirties the workouts stop paying you back the way they used to. The same lifts leave you sorer for longer. Sleep gets shallow. The stubborn ring of fat around the middle stops answering to diet. Nothing is wrong exactly, but the machine that used to rebuild you overnight has quietly turned down its own volume. There is a name for that dimming, somatopause, and there is a reason two small peptides keep coming up whenever men over 40 go looking for the switch. CJC-1295 and Ipamorelin are the two most discussed peptides for nudging that curve back up. They are not growth hormone. They are secretagogues, compounds that ask your own pituitary to release more of what it already makes. The real question is which one, or which combination, actually earns its place in the syringe after 40.

The Slow Fade Nobody Warns You About

Somatopause begins around age 30 and continues at a steady pace for the rest of life. It is easy to miss because it arrives without drama. There is no single morning where everything changes. Instead there is the gradual creep: less lean mass, more visceral fat, thinner skin, lighter sleep, slower recovery, and the low background fatigue that most men write off as simply getting older. Growth hormone output peaks in your twenties, then falls in a slow steady curve, roughly 14 percent per decade, for the rest of your life. The numbers behind the feeling are stark. Elderly men may produce as little as 50 micrograms of growth hormone per day, compared with the 1 to 1.5 milligrams a teenage boy produces, and about 35 percent of men over 60 test as growth hormone deficient. IGF-1, the downstream marker of that hormone, follows the same slide, sitting at only 30 to 50 percent of youthful levels by age 60 to 70. Charted by decade, IGF-1 drifts from 100 percent of peak in your twenties to the mid 80s in your thirties, into the low 70s at 40, and down toward a third of peak by your seventies. This is the biological backdrop against which peptide therapy makes its pitch. If the pituitary still works but simply speaks more quietly, maybe the answer is to turn the volume back up rather than pipe in a hormone from outside. The pituitary does not break with age. It just gets quieter, and secretagogues are a way of asking it to speak up.

The Growth Hormone Slide by Decade

IGF-1 as a rough percentage of youthful peak. Growth hormone output falls about 14 percent per decade after your twenties, and IGF-1 tracks the same steady slide.

IGF-1 (% of peak)

CJC-1295: The Steady Hand

CJC-1295 is a modified analog of growth hormone releasing hormone, the natural signal your hypothalamus sends to start a growth hormone pulse. The modification matters. Ordinary GHRH is gone from the bloodstream in minutes, while CJC-1295 is engineered to last, which is why it is often called the steady hand of the pair. The foundational human data comes from a 2006 study in the Journal of Clinical Endocrinology and Metabolism. A single injection raised growth hormone 2 to 10 fold for about six days and lifted IGF-1 by 1.5 to 3 fold for nine to eleven days. With repeated dosing, IGF-1 stayed above baseline for up to 28 days. Critically, the pulsatile rhythm of natural secretion was preserved rather than flattened into a constant drip, and that distinction is what separates a physiologic approach from crude hormone replacement. There are two versions worth knowing. CJC-1295 with DAC carries a drug affinity complex that stretches its half-life across days, meaning fewer injections and a long sustained IGF-1 elevation. CJC-1295 without DAC, often labeled Modified GRF 1-29, clears faster and gives sharper control over timing. For a man over 40 chasing lean tissue, joint and skin collagen, and a lower injection burden, the DAC version tends to be the anti-aging favorite. The trade is between convenience and control: the DAC form asks less of your schedule, while the non-DAC form lets you time pulses more precisely around training and sleep.

Ipamorelin: The Clean Pulse

Ipamorelin comes at the same goal from a different door. Rather than mimicking GHRH, it imitates ghrelin and binds the growth hormone secretagogue receptor in the pituitary, triggering a sharp immediate release. Its peak arrives roughly 40 minutes after dosing, and its half-life sits around two hours. Short, quick, and precise. Its reputation rests on selectivity. Ipamorelin is widely described as the cleanest of the growth hormone releasing peptides because it lifts growth hormone without meaningfully raising cortisol or prolactin. Older secretagogues in this family tended to spike stress hormones or trigger hunger, which quietly undercut the fat loss and muscle goals people were chasing. Ipamorelin largely sidesteps that, which is why it shows up in so many protocols aimed at body composition, recovery, and sleep. Put the two release curves side by side and the contrast is obvious. CJC-1295 builds a rounded, sustained elevation that is still meaningfully above baseline days later. Ipamorelin spikes hard within the first hour, peaking near a relative value of 0.85, then falls away to almost nothing within 24 hours. One holds a floor, the other lands a spike. Neither shape is better in isolation, because they answer different questions. The sustained curve asks how high the baseline sits across the day, while the sharp pulse asks how forcefully the pituitary can be triggered in a single moment. After 40, both of those answers have quietly gotten worse, which is exactly why the two peptides so often end up in the same protocol.

Two Peptides, Two Release Curves

Illustrative shape of the GH response over time after dosing. CJC-1295 raises a sustained baseline for days, while Ipamorelin drives a sharp pulse that peaks near 40 minutes and clears fast.

CJC-1295 (sustained)
Ipamorelin (sharp pulse)

Why the Two Get Stacked

Read the two profiles side by side and the logic of combining them almost writes itself. CJC-1295 raises the baseline and lengthens the window. Ipamorelin drives a strong clean spike on top of it. One is the tortoise, one is the hare, and they run as relay partners rather than rivals. When paired, Ipamorelin and CJC-1295 without DAC produce a synergistic effect, elevating both growth hormone and IGF-1 in a pulsatile, physiologic manner that mirrors the body's own rhythm more closely than either peptide alone. You get availability from one and intensity from the other. Scored across common goals, the division of labor is clear. CJC-1295 leads on lean mass and collagen or joint support, while Ipamorelin leads on fat loss, recovery, and sleep, and the combined stack meets or beats either one on every goal. In head to head terms, CJC-1295 is a GHRH analog with a release pattern sustained over days, a half-life measured in days with DAC, a low injection frequency, and a reputation built on lean mass, collagen, and anti-aging. Ipamorelin is a ghrelin mimic with a sharp pulse peaking near 40 minutes, a roughly two hour half-life, more frequent dosing, essentially no cortisol or prolactin effect, and a reputation built on fat loss, recovery, and sleep. For a man over 40 whose natural pulses have grown both smaller and less frequent, restoring both dimensions at once is the entire point.

What Each Lever Actually Moves

Relative strength across common goals on a 1 to 5 scale from the clinical and practitioner literature. The combined stack meets or beats either peptide alone on every goal.

CJC-1295
Ipamorelin
Combined Stack

So Which One After 40?

If you are forced to choose one, the honest answer runs by goal. Lean toward CJC-1295 if your priorities are lean muscle development, tissue and joint repair, collagen for skin and connective tissue, and the convenience of fewer injections. Lean toward Ipamorelin if your priorities are fat loss, faster recovery, and deeper sleep with a gentle pulse pattern and the lowest possible side effect profile. But most practitioners do not choose. For men over 40 the combination is the common recommendation precisely because aging erodes both the size and the frequency of natural pulses, and the stack addresses both at once. The timeline reported across clinics is consistent. Sleep and recovery improve in the first week or two. Energy climbs through weeks two to four. Visible body composition change tends to surface between weeks six and twelve, usually settling into full effect after a complete three to six month cycle. It is worth being honest about the evidence. Most of the human data measures hormone levels, not long term outcomes like strength, longevity, or quality of life, and the trials are small. These peptides also sit in a gray regulatory zone and are not FDA approved for anti-aging or performance. Real results depend on clinical supervision, lab monitoring, dose, and the unglamorous basics of training, protein, and sleep. A peptide amplifies a system that is already working. It does not replace one that is not.

What Changes, and When

Typical reported onset on a combined CJC-1295 plus Ipamorelin protocol. Sleep and recovery come first, body composition change surfaces between weeks 6 and 12, and full effect settles over a 3 to 6 month cycle.

The Clearest Way to Read All of It

Strip away the mechanisms and the release curves and the choice comes down to a simple picture. CJC-1295 rebuilds the room your growth hormone lives in. Ipamorelin turns the lights on sharply when you flip the switch. After 40, most men benefit from doing both, because the room has gotten smaller and the switch has gotten stickier at the same time. Addressing only one leaves half the problem in place. That framing also sets realistic expectations. The peptides are the easy part. The training, the protein, and the sleep are still what decide whether any of it shows up in the mirror. A secretagogue can restore a more youthful growth hormone rhythm, but it cannot manufacture a stimulus you never gave your body or recovery you never allowed. Used well, on top of a solid foundation and under proper supervision, the CJC-1295 and Ipamorelin stack is one of the more rational tools for pushing back on somatopause. Used as a shortcut around the basics, it is an expensive way to raise a lab value that never reaches the mirror. Start with the foundation, add the peptides with a clinician, monitor your labs, and let the combination do what it is actually good at: amplifying a system you are already taking care of.

#CJC-1295#Ipamorelin#Growth Hormone#Somatopause#Peptide Stacks#Anti-Aging

Frequently Asked Questions

Have more questions? Contact us or explore our full peptide intelligence platform.

Peptides & Longevity

MK-677 Restored Growth Hormone to Young-Adult Levels and Added Lean Mass. The Strength Never Showed Up.

MK-677, or ibutamoren, is an orally active growth hormone secretagogue that raised IGF-1 by about 84 percent and added roughly 1.1 kg of fat-free mass over two years in healthy older adults. In the same trial, muscle strength and physical function did not improve significantly, and fasting glucose rose while insulin sensitivity fell. An educational review of what the MK-677 trials actually measured, why lean mass and strength came apart, and the metabolic tradeoff that travels with the drug. Research framing, not medical advice.

11 min read min readAugust 19, 2026

Peptide Science

Tesamorelin: The Peptide That Targets Visceral Belly Fat in Men

An educational breakdown of tesamorelin, the GHRH analog studied for visceral fat reduction. What the Phase 3 trials measured, why it spares subcutaneous fat, how IGF-1 responds, and why the gains reverse after stopping. Research framing, not medical advice.

9 min read min readJuly 19, 2026